Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on June 3, 2026

Jun. 3, 2026

Pennant Expands Senior Living Presence with Pleasant Hill, California Community 

Indeterminate GlobeNewswire

Jun. 3, 2026

Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy

Indeterminate GlobeNewswire

Jun. 3, 2026

Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study

Indeterminate GlobeNewswire

Jun. 3, 2026

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 3, 2026

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF

Indeterminate GlobeNewswire

Jun. 3, 2026

Making Democracy Cute Again: Cutest Pets on Parliament Hill Crowns 2026 Winners

Indeterminate GlobeNewswire

Jun. 3, 2026

Rendre la démocratie attirante de nouveau : le concours « Les animaux de compagnie les plus mignons sur la Colline du Parlement » dévoile ses lauréats 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Indeterminate GlobeNewswire

Jun. 3, 2026

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

Indeterminate GlobeNewswire

Jun. 3, 2026

Hopstem hNPC01 Cell Injection Earns FDA RMAT Designation for Chronic Stroke Therapy

Indeterminate GlobeNewswire

Jun. 3, 2026

Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Indeterminate GlobeNewswire

Jun. 3, 2026

iHerb's 618 Big Benefits: Rewarding Users in Hong Kong and Southeast Asia

Indeterminate GlobeNewswire

Jun. 3, 2026

iHerb618重磅福利回饋香港及東南亞用戶

Indeterminate GlobeNewswire

Jun. 3, 2026

Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders

Indeterminate GlobeNewswire

Jun. 3, 2026

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative

Indeterminate GlobeNewswire

Jun. 3, 2026

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc

Indeterminate GlobeNewswire

Jun. 3, 2026

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Indeterminate GlobeNewswire

Jun. 3, 2026

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Inteleos and Medvarsity Partner to Expand Global POCUS Education Access

Indeterminate GlobeNewswire